BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its...
60 insider purchases on record · latest filing 2025-03-10.
Insiders have also filed 15 sale transactions at BIOA.